Related Experiment Video
Updated: Jun 13, 2026
11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Correlation between Claudins Expression and Prognostic Factors in Prostate Cancer
Kyung Won Seo1, Young Kee Kwon, Byung Hoon Kim
1Department of Urology, Keimyung University School of Medicine, Daegu, Korea.
Korean Journal of Urology
|April 30, 2010
Summary
Low expression of claudin-1 and claudin-5 in prostate cancer correlates with higher Gleason scores and elevated prostate-specific antigen (PSA) levels. These findings suggest claudins may serve as potential biomarkers for prostate cancer prognosis.
Area of Science:
- Oncology
- Molecular Biology
Background:
- Claudins are crucial tight junction proteins implicated in various cancers.
- Understanding claudin expression in prostate cancer is vital for prognostic assessment.
Purpose of the Study:
- To investigate the relationship between claudin-1 and claudin-5 expression and prognostic indicators in prostate cancer patients.
Main Methods:
- Analysis of 48 prostate cancer patient surgical samples.
- Correlation of claudin-1 and claudin-5 expression with Gleason score, PSA levels, and clinical outcomes.
Main Results:
- Low claudin-1 expression was significantly associated with Gleason score ≥7 (p=0.022) and higher PSA levels (p=0.007).
- Low claudin-5 expression was linked to Gleason score ≥7 (p=0.011) and elevated PSA (p=0.002).
- No significant association was found with T stage or recurrence.
Conclusions:
- Reduced expression of claudin-1 and claudin-5 are potential biomarkers for aggressive prostate cancer.
- These claudins may indicate higher Gleason scores and PSA values in prostate cancer.